The causal role of human papilloma virus (HPV) in cervical cancer is now well established and this has led to scientific inquiry into whether there is a role for HPV testing as a primary screening test, potentially replacing the Pap test. Several large randomized trials comparing Pap testing to HPV testing for primary screening have published results for one round of screening and for some trials the results are reported after two rounds of screening.
Results from the expert panel
|HPV testing for cervical cancer screening
The purpose of this document is to provide a summary of the key trials that have published results or are currently underway. This document will also explore potential impacts of HPV testing on screening, follow- up practices and future planning for these services. Released: March 29, 2012